project id: TCGA-UCEC; case submitter id: TCGA-DF-A2L0; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.9; rna integrity number: 8.5; age at index: 60; days to birth: -22200; days to death: 788; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; age at diagnosis: 22200; classification of tumor: not reported; figo stage: Stage IIIC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 520.0; portion submitter id: TCGA-DF-A2L0-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 5.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;